Importantly, CDKN2A has already been implicated as a regulator (64, 65) and biomarker (66) of human Alzheimer's disease (AD), however, its exact link to disease occurrence and progression is still unclear (67). The gene discussed is CDKN2A; the disease is early-onset autosomal dominant Alzheimer disease.